MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$519,905
EPS
-$0.38
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development expenses
243,226
186,331
235,992
227,442.75*
General and administrative expenses
276,610
210,311
287,922
527,816.25*
Total operating expenses
519,836
396,642
523,914
755,259*
Interest income
-
9,206
448
6,228.75*
Gain on disposal of subsidiaries
-
7,346,684
-
-
Interest (expense) income
-112
-
-
-
Other expense, net
-
-
-
65,712*
Other income (expense), net
31,006
42,930
136,565
-
Total other income (expense), net
30,894
7,398,820
137,013
-59,483.25*
Income (loss) before tax expense
-488,942
7,002,178
-386,901
-814,742.25
Loss from discontinued operation (net of tax)
-
-144,257
-
-
Net income (loss) for the period
-488,942
6,857,921
-386,901
-814,742.25*
Foreign currency translation gain, net of taxes
-
-
-86,539
54,586.5*
Foreign currency translation (loss) gain, net of taxes
-30,963
-380,403
-
-
Total comprehensive income (loss)
-519,905
6,477,518
-473,440
-760,155.75
Basic EPS
-0.38
0.31
-0.02
-0.037
Diluted EPS
-0.38
0.31
-0.02
-0.037
Basic Average Shares
1,284,923
21,640,000
21,640,000
20,525,699
Diluted Average Shares
1,284,923
21,640,000
21,640,000
20,525,699
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total comprehensive
income (loss)
-$519,905
Net income (loss)
for the period
-$488,942
Foreign currency
translation (loss) gain, net...
-$30,963
Other income
(expense), net
$31,006
Income (loss) before
tax expense
-$488,942
Total other income
(expense), net
$30,894
Interest (expense)
income
-$112
Total operating
expenses
$519,836
General and
administrative expenses
$276,610
Research and development
expenses
$243,226
Buy us a coffee
Advanced Biomed Inc. (ADVB)
Advanced Biomed Inc. (ADVB)